NewsRoom Articles - Page 635 of 1390

MondayFeb 17, 2020 1:00 pm

ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) Starts Presentation at NobleCon16

ProMIS Neurosciences (TSX: PMN) (OTCQB: ARFXF) is a development-stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The company’s proprietary target discovery platform is based on the use of two complementary thermodynamic, computational discovery engines - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. For more information, visit the company’s website at https://promisneurosciences.com/ About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

MondayFeb 17, 2020 1:00 pm

Euroseas Ltd. (NASDAQ: ESEA) Starts Presentation at NobleCon16

Euroseas (NASDAQ: ESEA) was formed in May 2005 to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas operates in the container shipping market. The company’s operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. The company has a fleet of 19 vessels, including 14 feeder containerships and five intermediate container…

MondayFeb 17, 2020 12:30 pm

EuroDry Ltd. (NASDAQ: EDRY) Starts Presentation at NobleCon16

EuroDry (NASDAQ: EDRY) operates in the dry cargo, drybulk shipping market. Company operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004-certified affiliated ship management company and Eurobulk (Far East) Ltd. Inc., which are responsible for the day-to-day commercial and technical management and operations of the vessels. EuroDry employs its vessels on spot and period charters. The company has a fleet of seven vessels, including four Panamax drybulk carriers, one Ultramax drybulk carrier and two Kamsarmax drybulk carriers. EuroDry’s seven drybulk carriers have a total cargo capacity of 528,931 dwt. For more information, visit the company’s website at…

MondayFeb 17, 2020 12:30 pm

Educational Development Corp. (NASDAQ: EDUC) Starts Presentation at NobleCon16

Educational Development (NASDAQ: EDUC) (“EDC”) is a publishing company specializing in books for children. EDC is the exclusive United States trade co-publisher of the line of educational children’s books produced in the United Kingdom by Usborne Publishing Limited, and also exclusively publishes books through its ownership of Kane Miller Book Publisher – both of which are international award-winning publishers of children’s books. EDC’s current catalog contains over 2,000 titles, with new additions semi-annually. Both Usborne and Kane Miller products are sold via 4,000 retail outlets and by independent consultants, who hold book showings in individual homes, through social media, book…

MondayFeb 17, 2020 12:30 pm

International Seaways Inc. (NYSE: INSW) Starts Presentation at NobleCon16

International Seaways (NYSE: INSW) is one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products in International Flag markets. International Seaways owns and operates a fleet of 42 vessels, including 13 VLCCs, two Suezmaxes, six Aframaxes/LR2s, 12 Panamaxes/LR1s and seven MR tankers. Through joint ventures, International Seaways currently has ownership interests in two floating storage and offloading service vessels. The company has an experienced team committed to the highest operating practices and the highest levels of customer service and operational efficiency. For more information, visit the company’s website at www.intlseas.com About NetworkNewsWire NetworkNewsWire…

MondayFeb 17, 2020 12:30 pm

Matinas BioPharma Inc. (NYSE: MTNB) Starts Presentation at NobleCon16

Matinas BioPharma (NYSE: MTNB) is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Matinas BioPharma is also developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections. The drug is based on the company’s proprietary lipid nano-crystal (LNC) platform technology which can help solve complex challenges relating to…

MondayFeb 17, 2020 12:00 pm

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) Starts Presentation at NobleCon16

BrainStorm Cell Therapeutics (NASDAQ: BCLI) is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The company holds the rights to clinical development and commercialization of the NurOwn® Cellular Therapeutic Technology Platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement as well as through its own patents, patent applications and proprietary know-how. Autologous MSC-NTF cells have received Orphan Drug status designation from the U.S. Food and Drug Administration (U.S. FDA) and the European Medicines Agency (EMA) for ALS. Brainstorm has fully enrolled the phase 3 pivotal trial in ALS (NCT03280056), investigating repeat-administration of autologous MSC-NTF cells at six…

MondayFeb 17, 2020 12:00 pm

Ely Gold Royalties Inc. (TSX.V: ELY) (OTCQB: ELYGF) Starts Presentation at NobleCon16

Ely Gold Royalties (TSX.V: ELY) (OTCQB: ELYGF) is an emerging royalty company with development assets focused in Nevada and Quebec. Its current portfolio includes 35 deeded royalties and 21 properties optioned to third parties. Ely Gold's royalty portfolio includes producing royalties, fully permitted mines and development projects that are at or near producing mines. The company is actively seeking opportunities to purchase existing third-party royalties for its portfolio and all the company's option properties are expected to produce royalties, if exercised. The royalty and option portfolios are currently generating significant revenue. Ely Gold is well positioned with its current portfolio…

MondayFeb 17, 2020 12:00 pm

ISG (Information Services Group) (NASDAQ: III) Starts Presentation at NobleCon16

ISG (Information Services Group) (NASDAQ: III) is a leading global technology research and advisory firm with more than 700 clients, including more than 70 of the Top 100 enterprises in the world. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry…

MondayFeb 17, 2020 12:00 pm

Trovagene Inc. (NASDAQ: TROV) Starts Presentation at NobleCon16

Trovagene (NASDAQ: TROV) is a clinical-stage Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including solid tumors, leukemias and lymphomas. Trovagene has intellectual property and proprietary technology that enables the company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics. For more information, visit the company’s website at https://www.trovageneoncology.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…